We and our partners use cookies and other tracking technologies to collect data relating to you to perform analytics, improve your experience of using our website, provide you with personalized ads and content based on your interactions with these and other websites and allow you to share content on social media. By clicking “Accept All Cookies”, you consent to this and to the sharing of this data with our partners. You can change your consent preferences at any time in the “Cookie Settings” section at the bottom of our website. Review our Cookie Notice to learn more about our practices.
CD158i Antibodies
The CD158i molecule (also known as p50.3) is a monomeric integral membrane glycoprotein of 50 kDa. This protein belongs to the family of NK receptors for MHC class I molecules. There is another comprehensive nomenclature which refers to this molecule as KIR2DS4; this acronym stands for Killer cell Immunoglobulin (Ig)-like Receptor (KIR), with extracellular part containing 2 Ig domains (2D), and a short (S) cytoplasmic tail. CD158i comprises 2 C-type extracellular Ig domains. The intracytoplasmic portion lacks characteristic ITIM motifs (Immunoreceptor Tyrosine-based Inhibition Motif) and displays a charged residue in the trans-membrane portion. CD158i receptor seems involved in NK cell activation, following HLA-Cw3 supertype recognition. Antibody-induced cross-linking of CD158i (p50.3) results in both early activation events and late effector function.
Clone: FES172 | Isotype: IgG2a Mouse |
The FES172 antibody stains NK subsets, but the p50.3 antigen appears to be expressed only by some individuals, and to be co-expressed with p58 KIRs. |
Resources + Tools